Gross Profit: Revenues from operations less the associated costs.
Emergent Biosolutions Inc. (EBS) had Gross Profit of $416.70M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$742.90M |
|
$52.60M |
|
$326.20M |
|
|
Gross Profit |
$416.70M |
$642.80M |
|
$100.10M |
|
$-17.30M |
|
$82.80M |
|
$82.80M |
|
$52.60M |
|
$52.60M |
|
$52.60M |
|
$52.60M |
|
$100.10M |
|
$205.70M |
|
53.50M |
|
56.70M |
|
$0.98 |
|
$0.93 |
|
| Balance Sheet Financials | |
$662.50M |
|
$205.40M |
|
$656.10M |
|
$1.32B |
|
$132.20M |
|
$572.10M |
|
$663.80M |
|
$796.00M |
|
$522.60M |
|
$86.10M |
|
$522.60M |
|
52.10M |
|
| Cash Flow Statement Financials | |
$170.60M |
|
$69.40M |
|
$-136.60M |
|
$105.60M |
|
$209.10M |
|
$103.50M |
|
$16.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.01 |
|
-- |
|
-- |
|
0.52 |
|
1.09 |
|
56.09% |
|
13.47% |
|
13.47% |
|
27.69% |
|
11.15% |
|
7.08% |
|
$195.00M |
|
-- |
|
-- |
|
-- |
|
0.56 |
|
0.95 |
|
8.82 |
|
41.37 |
|
10.07% |
|
61.09% |
|
3.99% |
|
4.80% |
|
$10.03 |
|
$3.44 |
|
$3.01 |
|